SOLOCAP-MAB
SOLOCAP-MAB, headquartered in France, is a prominent player in the biotechnology industry, specialising in monoclonal antibody development. Founded in 2010, the company has rapidly established itself as a leader in innovative therapeutic solutions, particularly in oncology and autoimmune diseases. With a focus on high-quality, bespoke monoclonal antibodies, SOLOCAP-MAB distinguishes itself through its advanced proprietary technologies and commitment to research excellence. The company has achieved significant milestones, including successful collaborations with major pharmaceutical firms, enhancing its market position. Operating primarily in Europe, SOLOCAP-MAB continues to expand its influence, driven by a dedication to improving patient outcomes through cutting-edge biopharmaceuticals. Its unique approach and robust pipeline of products underscore its reputation as a trusted partner in the biopharmaceutical landscape.
DitchCarbon Score
How does SOLOCAP-MAB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Paper Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SOLOCAP-MAB's score of 6 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SOLOCAP-MAB's reported carbon emissions
SOLOCAP-MAB, headquartered in France, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of concrete data, it is essential for SOLOCAP-MAB to establish clear climate commitments and reduction strategies to align with industry standards and demonstrate accountability in its environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SOLOCAP-MAB is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
